Patient Access

Timely by DrFirst Cuts PA Friction for Specialty Meds
Care Timely by DrFirst Cuts PA Friction for Specialty Meds

Why Prior Authorization Stalls Specialty Medications—and How Point-of-Care Tools Help Delays that drain patient momentum, inflate staff workload, and erode therapy starts rarely come from clinical indecision; they come from fragmented rules that surface too late to matter. Specialty medications c

Nebraska's First Test: Work Rules Squeeze Health Centers
Public Policy Nebraska's First Test: Work Rules Squeeze Health Centers

A sweeping Medicaid rewrite now asked low-income adults to report their work hours more often while states prepared to absorb less federal support, and the first hard edges of that policy pressed most quickly on the clinics that saw anyone who walked through the door, insured or not. The One Big

AI Mental Health Chatbots – Review
Care AI Mental Health Chatbots – Review

At two in the morning, when hotlines queue and clinics are closed, people are confiding in AI chatbots that reply instantly, cost less than a co-pay, and feel safer than risking judgment from a stranger. Introduction AI mental health chatbots have moved from curiosity to commonplace, stepping into

Alpha Therapies and Intratumoral Delivery Transform Oncology
Care Alpha Therapies and Intratumoral Delivery Transform Oncology

A quiet revolution gathered force each time a clinician asked a deceptively simple question with life-and-death stakes: could the deadliest radiation be guided to the tumor’s heart and fade before it harms everything else nearby, leaving behind a crater of damage in cancer cells and a smaller b

Direct-to-Patient Rx Unifies Access, Adherence, and ROI
Process Direct-to-Patient Rx Unifies Access, Adherence, and ROI

 The Access Gap No Consumer Would Tolerate Groceries arrived in under an hour with upfront pricing and one-tap checkout, yet a life-changing prescription often stalled for days behind opaque rules, surprise costs, and endless handoffs. That mismatch shaped more than frustration; it hardened into

FDA Approves Otarmeni to Treat Genetic Hearing Loss
Care FDA Approves Otarmeni to Treat Genetic Hearing Loss

A newborn infant resting in a quiet nursery currently possesses a world of silent potential that was once destined to remain forever beyond the reach of biological intervention. For decades, the standard of care for congenital deafness has been the cochlear implant, a marvel of engineering that

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later